Abstract
The expression of let-7 family members was differentiated in ischemic stroke (IS), functioning as an important regulating molecular in the pathophysiology of stroke. We hypothesized that genetic polymorphism in the promoters of let-7 family may be associated with the risk of IS. To test this hypothesis, we investigated the association of the rs10877887 and rs13293512 in the promoters of let-7 family with the susceptibility to IS. A hospital-based case–control study was performed. The rs10877887 genotype was determined by using a polymerase chain reaction-restriction fragment length polymorphism assay, and the rs13293512 genotype was determined by using a TaqMan assay. We found that the rs13293512CC genotype was associated with a reduced risk of IS (CC vs. TT: adjusted OR = 0.43, 95 % CI 0.26–0.71; dominant model: adjusted OR = 0.70, 95 % CI 0.49–0.98; recessive model: adjusted OR = 0.45, 95 % CI, 0.28-0.73). Stratification analysis showed that the rs10877887TT carriers had a higher level of total cholesterol compared to rs10877887TC/CC carriers (P = 0.03). Combined analysis showed that the rs10877887TC/CC and rs13293512TC/CC genotypes had a reduced risk of IS risk (adjusted OR = 0.58, 95 % CI 0.36–0.95). Our findings suggest that the rs13293512 polymorphism may be a protective factor for the development of IS.
Similar content being viewed by others
References
Feigin VL, Forouzanfar MH, Krishnamurthi R, Mensah GA, Connor M, Bennett DA, Moran AE, Sacco RL, Anderson L, Truelsen T, O’Donnell M, Venketasubramanian N, Barker-Collo S, Lawes CM, Wang W, Shinohara Y, Witt E, Ezzati M, Naghavi M, Murray C, Global Burden of Diseases I, Risk Factors S, the GBDSEG (2014) Global and regional burden of stroke during 1990–2010: findings from the Global Burden of Disease Study 2010. Lancet 383(9913):245–254
Goldstein LB, Adams R, Becker K, Furberg CD, Gorelick PB, Hademenos G, Hill M, Howard G, Howard VJ, Jacobs B, Levine SR, Mosca L, Sacco RL, Sherman DG, Wolf PA, del Zoppo GJ (2001) Primary prevention of ischemic stroke: a statement for healthcare professionals from the Stroke Council of the American Heart Association. Circulation 103(1):163–182
Warlow CP (1998) Epidemiology of stroke. Lancet 352 Suppl 3:SIII1–SIII4
Holmegard HN, Nordestgaard BG, Jensen GB, Tybjaerg-Hansen A, Benn M (2016) Sex hormones and ischemic stroke: a prospective cohort study and meta-analyses. J Clin Endocrinol Metabol 101(1):69–78. doi:10.1210/jc.2015-2687
Liu F, McCullough LD (2012) Interactions between age, sex, and hormones in experimental ischemic stroke. Neurochem Int 61(8):1255–1265. doi:10.1016/j.neuint.2012.10.003
Shinton R, Beevers G (1989) Meta-analysis of relation between cigarette smoking and stroke. BMJ 298(6676):789–794
Markus HS (2010) Genetics studies in ischaemic stroke. Translational stroke research 1(4):238–245. doi:10.1007/s12975-010-0041-5
Dichgans M (2007) Genetics of ischaemic stroke. Lancet Neurol 6(2):149–161. doi:10.1016/S1474-4422(07)70028-5
Flossmann E, Schulz UG, Rothwell PM (2005) Potential confounding by intermediate phenotypes in studies of the genetics of ischaemic stroke. Cerebrovasc Dis 19(1):1–10. doi:10.1159/000081905
Flossmann E, Schulz UG, Rothwell PM (2004) Systematic review of methods and results of studies of the genetic epidemiology of ischemic stroke. Stroke 35(1):212–227. doi:10.1161/01.STR.0000107187.84390.AA
Schulz UG, Flossmann E, Rothwell PM (2004) Heritability of ischemic stroke in relation to age, vascular risk factors, and subtypes of incident stroke in population-based studies. Stroke 35(4):819–824. doi:10.1161/01.STR.0000121646.23955.0f
Meschia JF, Atkinson EJ, O’Brien PC, Brott TG, Brown RD Jr, Hardy J (2003) Familial clustering of stroke according to proband age at onset of presenting ischemic stroke. Stroke 34(7):e89–e91. doi:10.1161/01.STR.0000078312.07274.A4
Mathonnet G, Fabian MR, Svitkin YV, Parsyan A, Huck L, Murata T, Biffo S, Merrick WC, Darzynkiewicz E, Pillai RS, Filipowicz W, Duchaine TF, Sonenberg N (2007) MicroRNA inhibition of translation initiation in vitro by targeting the cap-binding complex eIF4F. Science 317(5845):1764–1767. doi:10.1126/science.1146067
Soreq H, Wolf Y (2011) NeurimmiRs: microRNAs in the neuroimmune interface. Trends in molecular medicine 17(10):548–555. doi:10.1016/j.molmed.2011.06.009
Vickers KC, Remaley AT (2010) MicroRNAs in atherosclerosis and lipoprotein metabolism. Curr Opin Endocrinol Diabetes Obes 17(2):150–155. doi:10.1097/MED.0b013e32833727a1
Gubern C, Camos S, Ballesteros I, Rodriguez R, Romera VG, Canadas R, Lizasoain I, Moro MA, Serena J, Mallolas J, Castellanos M (2013) miRNA expression is modulated over time after focal ischaemia: up-regulation of miR-347 promotes neuronal apoptosis. FEBS J 280(23):6233–6246. doi:10.1111/febs.12546
Jeyaseelan K, Lim KY, Armugam A (2008) MicroRNA expression in the blood and brain of rats subjected to transient focal ischemia by middle cerebral artery occlusion. Stroke 39(3):959–966. doi:10.1161/STROKEAHA.107.500736
Selvamani A, Williams MH, Miranda RC, Sohrabji F (2014) Circulating miRNA profiles provide a biomarker for severity of stroke outcomes associated with age and sex in a rat model. Clin Sci 127(2):77–89. doi:10.1042/CS20130565
Jickling GC, Ander BP, Zhan X, Noblett D, Stamova B, Liu D (2014) microRNA expression in peripheral blood cells following acute ischemic stroke and their predicted gene targets. PLoS One 9(6):e99283. doi:10.1371/journal.pone.0099283
Sorensen SS, Nygaard AB, Nielsen MY, Jensen K, Christensen T (2014) miRNA expression profiles in cerebrospinal fluid and blood of patients with acute ischemic stroke. Transl Stroke Res 5(6):711–718. doi:10.1007/s12975-014-0364-8
Wang W, Sun G, Zhang L, Shi L, Zeng Y (2014) Circulating microRNAs as novel potential biomarkers for early diagnosis of acute stroke in humans. J Stroke Cerebrovasc Dis 23(10):2607–2613. doi:10.1016/j.jstrokecerebrovasdis.2014.06.002
Li SH, Su SY, Liu JL (2015) Differential Regulation of microRNAs in Patients with Ischemic Stroke. Curr Neurovascular Res 12(3):214–221
Long G, Wang F, Li H, Yin Z, Sandip C, Lou Y, Wang Y, Chen C, Wang DW (2013) Circulating miR-30a, miR-126 and let-7b as biomarker for ischemic stroke in humans. BMC neurology 13:178. doi:10.1186/1471-2377-13-178
Ni J, Wang X, Chen S, Liu H, Wang Y, Xu X, Cheng J, Jia J, Zhen X (2015) MicroRNA let-7c-5p protects against cerebral ischemia injury via mechanisms involving the inhibition of microglia activation. Brain Behav Immun 49:75–85. doi:10.1016/j.bbi.2015.04.014
Peng G, Yuan Y, Wu S, He F, Hu Y, Luo B (2015) MicroRNA let-7e is a potential circulating biomarker of acute stage ischemic stroke. Transl Stroke Res 6(6):437–445. doi:10.1007/s12975-015-0422-x
Selvamani A, Sathyan P, Miranda RC, Sohrabji F (2012) An antagomir to microRNA Let7f promotes neuroprotection in an ischemic stroke model. PLoS One 7(2):e32662. doi:10.1371/journal.pone.0032662
Liu Y, Zhang Y, Wen J, Liu L, Zhai X, Liu J, Pan S, Chen J, Shen H, Hu Z (2012) A genetic variant in the promoter region of miR-106b-25 cluster and risk of HBV infection and hepatocellular carcinoma. PLoS One 7(2):e32230. doi:10.1371/journal.pone.0032230
Li L, Pan X, Li Z, Bai P, Jin H, Wang T, Song C, Zhang L, Gao L (2013) Association between polymorphisms in the promoter region of miR-143/145 and risk of colorectal cancer. Hum Immunol 74(8):993–997. doi:10.1016/j.humimm.2013.04.019
Xu Y, Liu L, Liu J, Zhang Y, Zhu J, Chen J, Liu S, Liu Z, Shi H, Shen H, Hu Z (2011) A potentially functional polymorphism in the promoter region of miR-34b/c is associated with an increased risk for primary hepatocellular carcinoma. Int J Cancer 128(2):412–417. doi:10.1002/ijc.25342
Li L, Wu J, Sima X, Bai P, Deng W, Deng X, Zhang L, Gao L (2013) Interactions of miR-34b/c and TP-53 polymorphisms on the risk of nasopharyngeal carcinoma. Tumour Biol 34(3):1919–1923. doi:10.1007/s13277-013-0736-9
Gao LB, Li LJ, Pan XM, Li ZH, Liang WB, Bai P, Zhu YH, Zhang L (2013) A genetic variant in the promoter region of miR-34b/c is associated with a reduced risk of colorectal cancer. Biol Chem 394(3):415–420. doi:10.1515/hsz-2012-0297
Thayanithy V, Sarver AL, Kartha RV, Li L, Angstadt AY, Breen M, Steer CJ, Modiano JF, Subramanian S (2012) Perturbation of 14q32 miRNAs-cMYC gene network in osteosarcoma. Bone 50(1):171–181. doi:10.1016/j.bone.2011.10.012
Xie K, Liu J, Zhu L, Liu Y, Pan Y, Wen J, Ma H, Zhai X, Hu Z (2013) A potentially functional polymorphism in the promoter region of let-7 family is associated with survival of hepatocellular carcinoma. Cancer Epidemiol 37(6):998–1002. doi:10.1016/j.canep.2013.09.005
Wang Y, Wei T, Xiong J, Chen P, Wang X, Zhang L, Gao L, Zhu J (2015) Association Between Genetic Polymorphisms in the Promoter Regions of Let-7 and Risk of Papillary Thyroid Carcinoma: a Case-Control Study. Medicine 94(43):e1879. doi:10.1097/MD.0000000000001879
Liang Y, Zhao G, Sun R, Mao Y, Li G, Chen X, Gao L, Hu Z (2015) Genetic variants in the promoters of let-7 family are associated with an increased risk of major depressive disorder. J Affect Disord 183:295–299. doi:10.1016/j.jad.2015.04.035
Sima X, Sun H, Zhou P, You C (2015) A potential polymorphism in the promoter of let-7 is associated with an increased risk of intracranial aneurysm: a case-control study. Medicine 94(51):e2267. doi:10.1097/MD.0000000000002267
Chen P, Sun R, Pu Y, Bai P, Yuan F, Liang Y, Zhou B, Wang Y, Sun Y, Zhu J, Zhang L, Gao L (2015) Pri-Mir-34b/C and Tp-53 polymorphisms are associated with the susceptibility of papillary thyroid carcinoma: a case-control Study. Medicine 94(38):e1536. doi:10.1097/MD.0000000000001536
Adams HP Jr, Bendixen BH, Kappelle LJ, Biller J, Love BB, Gordon DL, Marsh EE 3rd (1993) Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. trial of org 10172 in acute stroke treatment. Stroke 24(1):35–41
Reinhart BJ, Slack FJ, Basson M, Pasquinelli AE, Bettinger JC, Rougvie AE, Horvitz HR, Ruvkun G (2000) The 21-nucleotide let-7 RNA regulates developmental timing in Caenorhabditis elegans. Nature 403(6772):901–906. doi:10.1038/35002607
Pasquinelli AE, Reinhart BJ, Slack F, Martindale MQ, Kuroda MI, Maller B, Hayward DC, Ball EE, Degnan B, Muller P, Spring J, Srinivasan A, Fishman M, Finnerty J, Corbo J, Levine M, Leahy P, Davidson E, Ruvkun G (2000) Conservation of the sequence and temporal expression of let-7 heterochronic regulatory RNA. Nature 408(6808):86–89. doi:10.1038/35040556
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Conflict of interest
The authors report no conflicts of interest.
Additional information
Li Zhang and Junsu Yang have contributed equally to this work.
Rights and permissions
About this article
Cite this article
Zhang, L., Yang, J., Xue, Q. et al. An rs13293512 polymorphism in the promoter of let-7 is associated with a reduced risk of ischemic stroke. J Thromb Thrombolysis 42, 610–615 (2016). https://doi.org/10.1007/s11239-016-1400-1
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11239-016-1400-1